chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I presented vaccination card indicating that previous dose was Moderna, but nurse said it didn't matter, they were similar, and gave me a dose of Pfizer vaccine anyway.
Information has been received from a health professional concerning a 74 year old female with hypothyroidism and post menopause who on 10/4/00 was vaccinated with pneumococcal vaccine 23 polyvalent in the left deltoid (633103/lot 1216J). On 10/5/00, the pt developed left upper arm redness, heat and minimal swelling. She was treated with methylprednisolone (Medrol Dosepak). Subsequently, the pt recovered. The reporter indicated that other pts experienced events following vaccination (WAES 01020487, 01020489, 01020490 and 00102088.) Additional information is not expected.
A spontaneous report from a health professional via VAERS concerns an 18 years old male. Concomitant medications and concomitant diseases were not reported. On an unknown date the patient received FLUMIST QUADRIVALENT (intranasal). The patient experienced fever and cough. The outcome of the fever and cough was unknown. The reporter assessed the fever and cough as serious due to medical importance. In the absence of reporter's causality the company physician considered the fever and cough to be related to the suspect drug FLUMIST QUADRIVALENT. Corrected report 17-Oct-2014: company causality changed from no to yes, narrative amended.
Pt recv vax on 3/3/99; 10 min post vax pt exp urticaria on face; tx=Benadryl
allergy like symptoms/allergy; nose running; congested and blockage in her nose; shortness of breath; couldn't sleep during the night; burning sensation in her chest; This is a spontaneous report from a contactable consumer. A 60-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date were not reported), via an unspecified route of administration on the upper left arm on 12Jan2021 16:00 at single dose for COVID-19 immunization. Medical history was not reported. There were no concomitant medications.  The patient reported that she took it yesterday and an hour into it she started having a burning sensation in her chest. What happen next, around 8pm, she started having allergy like symptoms that lasted throughout the night. She was experiencing nose running, congested and blockage in her nose, and shortness of breath. She couldn't sleep during the night until this morning. She had to breathe through her mouth because she couldn't' breathe through her mouth. For treatment, she took Mucinex tablets for allergy. She couldn't sleep during the night until this morning. She had to breathe through her mouth because she couldn't' breathe through her mouth. This was the first dose, her second dose is due on 02Feb2020 and she wants to know if she can skip it.   Before she got it she contacted her primary care due to having allergies before the vaccine and asked if she should take; she was told to hold on but then she went ahead and took it. Within the first 30 minutes she was ok but in an hour is when she had the burning sensation in her chest. The burning sensation lasted about an hour. The dose was administered around 4pm on 12Jan2021.The caller reports that the Mucinex and she has breathing treatment, nebulizer treatments for her lungs, that she did and these things helped. Early this morning she felt she can now close her mouth and breathe normally. It was administered in the upper left arm. She did not require a visit to the doctor or ER. The patient has had no reactions to vaccines in the past nor were any administered on the day of or within the prior 4 weeks. Therapeutic measures were taken as a result of allergy like symptoms, congested and blockage in her nose and shortness of breath which included Mucinex. The patient recovered from burning sensation in her chest on 12Jan2021, from allergy like symptoms/allergy and shortness of breath on 13Jan2021 while the outcome of the other events was unknown.  Information on the lot/batch number has been requested.
INJECTION SITE SORENESS/ LIGHT SENSITIVITY/ FATIGUE/ SLIGHT HEADACHE REST; NAPROXIN
About 1wk. from vaccination, she began to have pain & tingling in her feet. She stayed tired all the time. She had gout in her feet before and thought it was gout. She went to the Dr. and he gave her QUININE for her legs cramping. This helped a little but kept getting worse, went to hospital on 5-25-09 Died 7-5-09.  11/5/09 Death Certificate received DOD 7/5/09 Cause of Death: Respiratory Failure consistant with Adult Respiratory Distress Syndrome.
This spontaneous report as received from a physician refers to a female patient of unknown age with no drug reactions/allergies, who in 1997 was vaccinated with a dose of unknown pneumococcal vaccine, polyvalent (23-valent)(manufacturer unknown) (dose, route and lot # not reported) and experienced severe injection site reaction with swelling. No other co-suspects were reported. No concomitant medications were reported. The physician was unable to determine the name or manufacturer of this vaccine. The patient had received other unknown vaccines since 1997, and had not an adverse experience. The outcome of severe injection site reaction with swelling was reported as recovered/resolved (date unknown). The patient sought unspecified medical attention. The relatedness for severe injection site reaction with swelling was unknown for pneumococcal vaccine, polyvalent (23-valent)(manufacturer unknown). Additional information has been requested.
within  a few hours of receiving J&J vaccine, she started having nausea, vomiting and diarrhea. She then started having increased arthralgias with myalgias. She was unable to tolerate foods or liquids for 36 hours. She required IV hydration. 5 large whelps present to back with scattered fine rash to entire body (no itching or irritation). Denied fever, but did complain of chills.
Information has been received regarding a case in litigation concerning a child who was injected with vaccinations containing the toxic mercury based preservative thimerosal from August 1997 through at least October 1998. The alleged result of these vaccinations is that the patient suffers from and in the future will continue to suffer the toxic neurological effects of mercury poisoning. Immunization information (lot numbers were not reported) reported that the patient was vaccinated with B vaccine recombinant (yeast)(manufacturer unknown) on 8/7/97, 11/10/97 and 4/21/98; diphtheria toxoid (+) pertussis vaccine (+) tetanus toxiod (manufacturer unknown) on 9/17/97, 11/10/97, 1/30/98 and 10/23/98; haemophilus B conjugate vaccine (manufacturer unknown) on 9/18/97, 11/10/97,  1/30/98 and 10/23/98. Upon internal review, mercury poisoning and neurological disorder were considered to be an other important medical event. No further information is available.
after receiving flu vaccine returned to her desk felt dizzy, left side of face felt itchy and numb. Benadryl administered, IV normal saline inserted. Transported to ED, methylprednisolone 4mg. dosepack prescribed on discharge
Main symptom was dizziness. Started doctoring on November 3, 2005/shot administered on November 1, 2005 and I woke up on November 2, 2005 with the symptoms. I was feeling great before the vaccine. The symptoms developed into ear infection, rhinitis, sinustitis (I already have chronic sinusitis) but symptoms worsened. I am still being treated by ENT doctors for ear trouble. I had to have sinus x rays, cat scan (facial) and medications to fight this condition and am still doctoring for flu like symptoms which are ear aches, body aches, neck pain and bad headaches.  This has resulted in a lot of medical bills so far to fight this problem. I have already had 6 doctor visits and the two x rays. Doctor will not rule that this illness is a reaction to the flu shot, but I think that it is more than a coincidence that the morning after the vaccine, 20 hours I would wake up sick and still have to be treated for flu type symptoms.  This has caused hardship for paying bills and trying to work while sick.  Thanks.
Lethargic, no energy, achy, sore, tired, headache, slept for 3 days
3 separate events of freezing with severe chills, rigor/uncontrollable shaking (9/3 8:30pm-9:15pm; 9/4 3:48am-5:57am; 9/4 10:11am-11:44am) Numbness and tingling in fingertips (9/3 8:45pm-9:15pm) Muscle aches (started 9/3 at 9:30pm and during shakes) High fever (started 9/3 at 9:30pm until 9/4 at 5:12pm; highest 103.8 12:18pm on 9/4) Moderate headache (began 9/4 at 3:48am, still ongoing) Moderate nausea (began 9/4 at 10:11am, and still ongoing) Took Ibuprofen 800mg 9/3 at 10:30pm Took Tylenol extra strength 1000mg at 5:16am and at 10:43am Took Ibuprofen 800 mg at 2:12pm Took Tylenol 1000mg at 5:12pm Took Ibuprofen 800mg at 8:12pm
mom reported w/in 3 hrs p/shot pt t102, lt thigh swollen to 1 in below knee, face swollen & red; notified MD; pt w/hx of previous allergies; MD told mom to watch pt for 24 hrs; AM of 14APR93, t102.5; MD reports pt sensitive to vax;
pt became pale, felt clammy to touch, unresponsive to stimuli, (visual, verbal, touch); muscle tone limp; episode lasted 1/2 hrs; mom spoke to MD;
This spontaneous report as received from a physician refers to a  patient of unknown age and gender. On 15-APR-2015, the patient was vaccinated with improperly stored PNEUMOVAX (lot # K024976 exp date 09-JUN-2016) (dose and route not reported). The temperature and time of excursion was 1.11 degrees C for 64 hours. The vaccine status was reported as "in excursion", the storage criteria and the vaccine excursion were reported as "Refrigerator (R)". No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
DEATH; COMPLICATIONS FROM THE VACCINE; This spontaneous report received from a consumer concerned an adult male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported, once total for prophylactic vaccination. The batch number was not reported. In this scenario follow-up is not required to obtain batch/lot numbers. No concomitant medications were reported.  On an unspecified date, two months after vaccination, the patient died of unknown cause. The patient death occurred in hospital. It was also stated that patient had some unspecified complications. iT was also reported that, patient was healthy man in his early sixties. It was unknown, whether autopsy was performed or not. On an unspecified date, the subject experienced death, and complications from the vaccine.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died of death on an unspecified date, and the outcome of complications from the vaccine was not reported. This report was serious (Death).; Sender's Comments: V0:-covid-19 vaccine ad26.cov2.s-Death. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s); Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
pt returns in large, erythematous area on the rt deltoid @ site of inject; area is swollen & hot to touch assessed by MD as allergic rxn;
Pt got PREVNAR 13 on Monday 9/16/13. On Saturday 9/21/13 patient has swelling, red, itchy patch size of baseball and as of today Monday 9/23/13 symptoms persist.
Body aches, low grade head ache, 102 fever, swollen and tender lymph node in left armpit. Lasting over 24hrs
12/4/2022:  Presented to the ED with generalized weakness and chills in the setting of COVID-positive yesterday.  Started to develop some fatigue, weakness, nausea, cough, and nasal congestion. Not eating or taking meds due to nausea. Presented to the ED and was initially discharged home. Returned to the ED the next day due to increased weakness. Admitted for weakness and severe hyponatremia. Noted to have returned to the ED also 12/18/2023 with Covid symptom complaints. No evidence of re-admission at that time.  Submitter does not have access to further medical information on this case. If more information is needed, please contact the admitting hospital.
This spontaneous report as received from a consumer (patient's father) refers to a 17-year-old male patient. There were no concurrent condition and medical history reported. The patient did not have allergy. On 03-OCT-2011, the patient was vaccinated with the first dose GARDASIL "one single shot" (route of administration, strength, lot number and expiration date were not reported). Concomitant therapies included FLUZONE (Sanofi Pasteur). On 03-OCT-2011, "immediately" after vaccination, the patient experienced headache. The patient has been seen by numerous specialists; he has been taken to the hospital, and spent a 17-day treatment program at the "Institute, in the fall of 2012,". The patient's father stated that his son has had "no relief" from the many unspecified medications he has been given as headache treatment; these medications "affected his sleep and caused stomach problems." However, patient's father also said that his son "had success" with unspecified IV medications, but this "wasn't matched with the other medications." The patient has been to the emergency room 3 times, where he would be given a "migraine cocktail that included (BENADRYL)" and stayed overnight one time (date unknown) at an unspecified hospital". Lab diagnostic studies included: magnetic resonance imaging (MRI), blood work and spinal puncture on an unknown date (results not provided). Therapy with GARDASIL was discontinued after receiving first injection (on 03-OCT-2011). The outcome of events was unknown. The relatedness between adverse events and therapy with GARDASIL was not reported. Additional information has been requested.
CONFIRMED CLINICAL VACCINATION FAILURE; CONFIRMED COVID-19 INFECTION; This spontaneous report received from a patient concerned a 35 year old male of unspecified race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: no alcohol use, smoker (marijuana) and other pre-existing medical conditions included: The patient had nothing worth mentioning history, The patient had no known drug allergies and no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A and expiry: UNKNOWN) dose was not reported, 1 total, administered on 02-JUN-2021 to left arm for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date in OCT-2021, about 4 months after vaccination, the patient was diagnosed with clinically confirmed COVID-19 test (Confirmed Clinical Vaccination Failure) at doctor's office and the patient stated that it was not rapid test as he had to wait for a few hours but he did not remember exactly what kind of test it was. Patient stated that he chose Janssen vaccine because it is only one shot and he has bad response to needles (crying and shaking even hours after the shot) and also he mentioned that it is really embarrassing. He was little annoyed that he still got really sick with COVID-19 even after vaccination and spread it so easily to other family members. His other family members were vaccinated with different vaccine and his 3-year-old daughter was not vaccinated. Patient stated that he wears his mask religiously. He also stated he was sick for 2 weeks and needed 3 extra days from the 5 day's quarantine guidelines. Patient did not really remember when he got sick but he stated he was in quarantine on Halloween day. He also mentioned that he did not get sick as bad as his other family members. He and his unvaccinated 3-year-old daughter got it the least. Patient stated he is not and anti-vaxxer but he believes that COVID-19 vaccine is as effective as flu shot which is not really effective. Laboratory data included: COVID-19 virus test (NR: not provided) Positive COVID-19 infection. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from confirmed covid-19 infection, and the outcome of Confirmed Clinical Vaccination Failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint: 90000216622.; Sender's Comments: V0:20220220795- Covid-19 vaccine ad26.cov2.s- Confirmed clinical vaccination failure. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS
Left arm became extremely sore down to fingertips. Patient  could not hold onto anything as fingers hardly could move.  After two days his hand swelled up.  I almost took him to Urgent care but said he was getting g a little better.
pt recvd vax & became dizzy, cold, clammy, w/a metallic taste in mouth
Dizziness; Nausea; This spontaneous case was reported by a nurse and describes the occurrence of DIZZINESS (Dizziness) and NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jul-2021, the patient experienced DIZZINESS (Dizziness) and NAUSEA (Nausea). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Nausea, at an unspecified dose and frequency. At the time of the report, DIZZINESS (Dizziness) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Non-Significant follow up received on 26-JUL-2021 - AE contact information updated. On 27-Jul-2021: Non-Significant Follow up received on 27-JUL-2021
Patient had severe migraine headache on 4/10 (3 days after vaccine) with nausea, visual aura, eye pain and photosensitivity. No prior history of migraine. Had virtual visit today, 4/13 and continues to have bilateral eye pressure, dizziness and intermittent headache with photosensitivity.
Pt woke up with welt measuring 1/2-1 inch in diameter on buttocks raised area on buttocks also on top of feet welt measuring 1/20-1 inch in diameter. It has been itching. Also quarter size. Pinkish in color slightly raised at injection site. Pt has been taking BENADRYL oral tablets as well as applying cortisone cream. Pt reports welts morning of the 10/29/15.
it got very swollen and red/purple it was at least 4 cm in diameter. with ice packs it finally improving  still swelling under arm With #1 gardasil she was fine  She did have pain down her left arm  which is resolved
Headache, HYPERtension, stated having headache and elevated blood pressure, initial bp was 136/104, 1 recheck in clinic was 126/81 Narrative:
Arm is swollen and warm at injection site. Body aches and fatigue.  Light headed.  Headache
Optic neuritis in the left eye and periodic joint pain. Visual exams show loss of vision in the left eye. 6/24/02 Medical records note additional symptoms of fatigue and one week of recurrent epistaxis. The annual follow up states "no central vision in my left eye."
Patient had a syncopal episode while on the toilet and moving her bowels on night of 4/15. She struck head and sustained left peri-orbital laceration.  Was seen at ER on 4/16. Had CT of head showing cutaneous injury only. Was discharged home.  On 4/20 she first noted swelling in right calf. This worsened and was seen in Care Center on 4/23. Had high D-dimer and had ultrasound of leg at ER. This showed right leg DVT extending from the distal femoral vein through the popliteal and posterior tibial veins. She had a long wait and left. She called PCP's on 4/24 on was prescribed Eliquis. She had trouble getting prescription filled due to cost and need for insurance pre-approval. Finally picked up and started Eliquis on the morning of 4/25. She contacted PCP's office on morning of 4/26 with new complaint of "terrible shortness of breath and lightheadedness". Patient was seen. CTA of chest done at hospital. showed "a large bilateral acute bilateral pulmonary embolism with saddle embolus, involving the right and left main pulmonary arteries, as well as the lateral lower lobe, upper lobe, right middle lobe, and lingular segmental and subsegmental branches. There is slight bowing of the interatrial ventricular septum to the left consistent with right heart strain." Patient to be admitted for thrombectomy
Cellulitis of left thigh on July 9, 2008 - two days after vaccines were administered.  Patient had a large amount of swelling and redness on left thigh. Patient was started on Amox 1 tsp BID for 10 days.
Approximately 24 hours after vaccine was administered, patient reported diffuse bruising on left arm, starting approximately half way between elbow & deltoid, and continuing approximately 5 inches down forearm from the elbow. Patient did not report any redness, tenderness, or warmth/heat where bruising occurred. Patient did not seek any medical attention, nor did he notify the administering pharmacy until 9/21/17.
the patient thought the needle was still in his arm; the patient thought the needle was still in his arm; a hard mass at the injection site; pain from the neck down; This spontaneous report was received from a registered pharmacist and refers to a 58-year-old male patient. The patient's pertinent medical history included hypertension, high cholesterol and hydrocephalus. The patient had no drug reactions or allergies. His concomitant medications included cyanocobalamin, acetazolamide, anastrozole, hydrochlorothiazide (+) lisinopril and rosuvastatin.  On 22-MAR-2019, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), one time dose, intramuscularly, lot # R031961, expiration date 09-JUN-2020, for prophylaxis.   On 22-MAR-2019, the patient experienced pain from the neck down and a hard mass at the injection site. The patient though the needle was still in his arm. Therefore, on an unknown date, he saw his health care professional. He was exanimated and got an x-ray (results not provided). At the reporting time, the patient did not recover from the events. The relatedness between the events and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was not provided.  The pharmacist reported that the events caused significant disability or incapacity. It was unknown whether the patient was hospitalized due to the events. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; manufactureraddress:; manufacturercity:; manufacturerstate:; manufacturercountry:; devicelotnumber: R031961; expirationdate: 09-JUN-2020; deviceage and unit: 0 ; operatorofdevice: Pharmacist; malfunction: Unknown; deviceusage: Unknown; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not suggest a causal association with the device or device constituent
Reports he had muscle tenderness, swelling and redness after shot was given. Reports he still has muscle soreness and  some limitation of movement if he moves his arm a certain way